Genome editing to create personalized safe and effective medicines
Genome editing gives precise control of the type of genetic modification made to a cell. Hematopoietic stem cells have pharmacologic properties of durability and output that still remain untapped. Matthew Porteus and his group are using genome editing of hematopoietic stem cells to develop new classes of drugs to treat patients.
Die Veranstaltung ist Teil des CAS-Schwerpunkts CRISPR/Cas.
- Prof. Matthew Porteus, Sutardja Chuk Professor of Definitive and Curative Medicine at Stanford University
- Prof. Dr. Christoph Klein, LMU
Prior registration by email is required. For further information, see the CAS website.
The Center for Advanced Studies at LMU provides a forum for scientific exchange and discussion that bridges the divide between the established disciplines. Its activities are designed to promote all forms of collaborative research and to stimulate interdisciplinary communication within the University. In addition, it facilitates the integration of visiting scholars and scientists into the academic life of the University.